Anne R. Meibohm
- Infectious Diseases top 0.5%
- Virology top 0.2%
- Epidemiology top 5%
- Emergency Medicine top 2%
- Immunology
- Co-authors
- John W. MellorsEmilio A. EminiJeffrey ChodakewitzRoy M. GulickJoseph J. EronDouglas D. RichmanDiane V. HavlirCharles J. Gonzalez
- Topics
- HIV/AIDS drug development and treatment (12 papers)HIV Research and Treatment (11 papers)HIV/AIDS Research and Interventions (10 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Anne R. Meibohm
26 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Infectious Diseases 2.1k
- Virology 1.9k
- Epidemiology 555
- Emergency Medicine 295
- Immunology 193
Countries citing papers authored by Anne R. Meibohm
This map shows the geographic impact of Anne R. Meibohm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne R. Meibohm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne R. Meibohm more than expected).
Fields of papers citing papers by Anne R. Meibohm
This network shows the impact of papers produced by Anne R. Meibohm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne R. Meibohm. The network helps show where Anne R. Meibohm may publish in the future.
Co-authorship network of co-authors of Anne R. Meibohm
This figure shows the co-authorship network connecting the top 25 collaborators of Anne R. Meibohm. A scholar is included among the top collaborators of Anne R. Meibohm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne R. Meibohm. Anne R. Meibohm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 27 | |
| 4 | 24 | |
| 5 | 53 | |
| 6 | 84 | |
| 7 | 6 | |
| 8 | 4 | |
| 9 | 16 | |
| 10 | 11 | |
| 11 | 50 | |
| 12 | 122 | |
| 13 | 154 | |
| 14 | 86 | |
| 15 | 56 | |
| 16 | 207 | |
| 17 | Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapybreakdown → | 1531 |
| 18 | 9 | |
| 19 | 7 | |
| 20 | Migraine prevention with timolol. A double-blind crossover study. | 45 |
About Anne R. Meibohm
Anne R. Meibohm is a scholar working on Virology, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 27 papers that have together received 2.9k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (11 papers) and HIV/AIDS Research and Interventions (10 papers). The work is most often cited by research in Virology (1.9k citations), Infectious Diseases (2.1k citations) and Emergency Medicine (295 citations). Anne R. Meibohm has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include John W. Mellors, Emilio A. Emini, Jeffrey Chodakewitz, Roy M. Gulick, Joseph J. Eron, Douglas D. Richman, Diane V. Havlir, Charles J. Gonzalez, Leslie Jonas and Jon H. Condra. Their work appears in journals such as New England Journal of Medicine, JAMA and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.